Addison Capital’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-6,334
Closed -$1.12M 121
2020
Q1
$1.12M Sell
6,334
-83
-1% -$15.6K 0.82% 44
2019
Q4
$1.23M Sell
6,417
-382
-6% -$68.9K 0.81% 36
2019
Q3
$1.14M Sell
6,799
-23
-0.3% -$3.75K 0.81% 37
2019
Q2
$1.14M Sell
6,822
-301
-4% -$41.7K 0.8% 38
2019
Q1
$1.04M Sell
7,123
-75
-1% -$10.9K 0.79% 43
2018
Q4
$962K Sell
7,198
-662
-8% -$109K 0.86% 40
2018
Q3
$1.5M Buy
7,860
+481
+7% +$88.4K 1.12% 32
2018
Q2
$1.23M Sell
7,379
-80
-1% -$12.8K 0.95% 34
2018
Q1
$1.25M Sell
7,459
-1,458
-16% -$245K 1.02% 36
2017
Q4
$1.46M Sell
8,917
-1,061
-11% -$190K 1.15% 30
2017
Q3
$2.04M Sell
9,978
-583
-6% -$136K 1.79% 21
2017
Q2
$2.57M Buy
10,561
+319
+3% +$75K 2.05% 14
2017
Q1
$2.45M Buy
10,242
+192
+2% +$44.7K 1.97% 16
2016
Q4
$2.11M Sell
10,050
-908
-8% -$188K 1.86% 16
2016
Q3
$2.52M Buy
10,958
+2,705
+33% +$661K 2.21% 8
2016
Q2
$1.91M Sell
8,253
-4,378
-35% -$1.01M 1.72% 22
2016
Q1
$3.38M Buy
12,631
+4,665
+59% +$1.34M 2.58% 2
2015
Q4
$2.49M Sell
7,966
-181
-2% -$53.9K 1.95% 12
2015
Q3
$2.21M Sell
8,147
-3,190
-28% -$980K 2.06% 15
2015
Q2
$3.44M Buy
+11,337
New +$3.38M 3.13% 5

Other funds holding AGN

Addison Capital's AGN Position: Q2 2020 in Review

Addison Capital sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 6,334 shares — an estimated $1.12M sold.

Addison Capital first reported a position in AGN in Q2 2015 and held it in 20 quarters. The position peaked at $3.44M in Q2 2015. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Addison Capital reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Addison Capital sold 6,334 Allergan plc shares in Q2 2020, an estimated $1.12M.
  • Addison Capital first reported a position in Allergan plc in Q2 2015 and held it in 20 quarters.
  • Addison Capital's Allergan plc position peaked at $3.44M in Q2 2015.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Addison Capital's 13F filing for Q2 2020, filed 16 Jul 2020.